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論文の要旨 
Abstract of thesis 
(Background/Purpose) 
Two pluripotent stem cells (PSCs): embryonic stem cells (ESCs) and epiblast stem cells (EpiSCs) 
represent naïve and primed pluripotent states which exhibit significant differences. PSCs possess the 
capacity to self-renew and differentiate into various type of cells. Heterogeneity is one of the underlying 
mechanisms which might keep PSCs to have the capacity to self-renew under various environments. 
However, how heterogeneity evolves as a molecular basis for PSC self-renewal and undifferentiated 
remains unclear. The author would like to investigate as following: 
- to examine how the heterogeneity of ESCs is regulated focusing on Rex-1 gene expression which is 
a well-known pluripotent gene expressed in a heterogeneous pattern 
- to investigate whether EpiCSc have different subpopulations that vary in differentiation ability 
focusing on Fgf5 gene expression 
氏     名 Le Tran Phuc Khoa   
学 位 の 種 類       E 博士（ 人間生物学  ） 
A学 位 記 番 号       E 博甲第   8312   号 
A学位授与年月       E 平成 29年 3月 24日 
A学位授与の要件       E 学位規則 第４条第１項該当（昭和２８年４月１日文部省令第９号） 
審 査 組 織 グローバル教育院 
学位論文題目  Regulat ion of  Transcript ional Heterogeneity in Plur ipotent  
Stem Cells 
 (多能性幹細胞における転写不均一性の制御 )  
 （職名） （学位） （氏名） 
主   査 筑波大学教授 博士（医学） 大根田 修 
副   査 筑波大学教授 医学博士 高橋 智 
副   査 筑波大学准教授 博士（薬学） 鈴木 裕之 
副   査 筑波大学教授（グローバル教育院） Ph.D. Tilo Kunath 
 (Material and methods) 
To investigate the mechanisms of regulation of ESCs heterogeneity, the author used a double knock-
in cell line, OCRG9 ES cells, where fluorescent genes were inserted into Oct3/4 and Rex1 genes, 
respectively. Then the author examined gene expression between Rex-1-positive and –negative 
populations, and found significant differences in the expression of glycolysis- and antioxidant-related 
genes. Therefore, the author used pharmacological and genetic approaches to explore the effects of 
glycolysis and ROS signaling pathway on the regulation of ESCs heterogeneity. 
To examine the heterogeneity in EpiSCs, the author generated Fgf5 transgenic EpiSCs with Venus 
gene and examined heterogeneous expression of FgF5 at E6.5 and E7.5 embryos. 
 
(Results) 
  1) The author found that Rex-1-negative population show increased expression associated with 
glycolysis pathway, such as Glut1, Gapdh, Pgk1, Eno3, and Ldha 
  2) The author found that suppression of glycolysis pathway using glycolysis inhibitors, 2-DG and 2-FDG 
affected the temporal interchange of intercoversion of Rex-1 positive and Rex-1-negativie cells 
  3) The author found that Hk2 gene-knocked out ESCs showed a reduction of Rex-1-negative cells, 
suggesting that glycolysis pathway is an intrinsic factor regulating ESC heterogeneity 
  4) The author found that ROS generation downstream of glycolysis inhibition is an essential factor 
regulating the process of the conversion between Rex-1-positive and –negative 
  5) The author found that the reduction of ROS inhibited the re-establishment of ESC heterogeneity from 
both Rex-1-positive and –negative cells 
  6) The author found that Fgf5-positive EpiSCs showed mesodermal markers while Fgf5-negative 
EpiSCs showed ectodermal markers 
 
 
 
審査の要旨 
 Abstract of assessment result 
 
【批評 Review】 
The author showed us that Rex-1-negative cells preferentially possessed glycolysis pathway with cell 
survival activity rather than Rex-1-positive cells. Of note, the author demonstrated that glycolysis inhibition 
abolished the Rex-1-positive cell enrichment derived from Rex-1-negative cells, indicating the importance 
of the glycolysis in the heterogeneity of ESC development.  
We asked the author about the physiological and scientific importance of metabolic changes from the 
sate of ESCs to EpiSCs and the author clearly explained the biological importance of the existence of 
heterogeneity situation during the early development of pluripotent stem cells. We also asked the author 
the method how to detect the measurement of metabolic changes besides the changes of metabolic gene 
transcriptions. The author showed us the possibility of the measurement that would be useful to detect. 
 
 【最終試験の結果 Result】 
The final examination committee conducted a meeting as a final examination on January 13th, 2017. 
The applicant provided an overview of dissertation, addressed questions and comments raised during 
Q&A session. All of the committee members reached a final decision that the applicant has passed the 
final examination. 
 
【結論 Conclusion】 
Therefore, the final examination committee approved that the applicant is qualified to be awarded 
Doctor of Philosophy in Human Biology. 
 
 
